Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
resolution of basal cell carcinoma
Stephen B Tucker, M.D.
University of Texas Health Science Center of Houston Dermatology Clinic
United States: Institutional Review Board
|University of Texas Health Science Center of Houston Dermatology Clinic||Houston, Texas 77030|